Literature DB >> 31484735

T Cell- and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer.

Michael L Washburn1, Zhang Wang2,3, Andrew H Walton4, S Peter Goedegebuure5,6, David J Figueroa2, Stephanie Van Horn2, Julie Grossman5, Katja Remlinger2, Heather Madsen2, James Brown2, Roopa Srinivasan2, Amaya I Wolf2, Scott B Berger2, Victoria N Yi4, William G Hawkins5,6, Ryan C Fields5,6, Richard S Hotchkiss7,5,8.   

Abstract

Sepsis is characterized as life-threatening organ dysfunction caused by a dysregulated host immune response to infection. The purpose of this investigation was to determine the differential effect of sepsis on innate versus adaptive immunity, in humans, by examining RNA expression in specific immune cell subsets, including monocytes/macrophages and CD4 and CD8 T cells. A second aim was to determine immunosuppressive mechanisms operative in sepsis that might be amenable to immunotherapy. Finally, we examined RNA expression in peripheral cells from critically ill nonseptic patients and from cancer patients to compare the unique immune response in these disorders with that occurring in sepsis. Monocytes, CD4 T cells, and CD8 T cells from septic patients, critically ill nonseptic patients, patients with metastatic colon cancer, and healthy controls were analyzed by RNA sequencing. Sepsis induced a marked phenotypic shift toward downregulation of multiple immune response pathways in monocytes suggesting that impaired innate immunity may be fundamental to the immunosuppression that characterizes the disorder. In the sepsis cohort, there was a much more pronounced effect on gene transcription in CD4 T cells than in CD8 T cells. Potential mediators of sepsis-induced immunosuppression included Arg-1, SOCS-1, and SOCS-3, which were highly upregulated in multiple cell types. Multiple negative costimulatory molecules, including TIGIT, Lag-3, PD-1, and CTLA-4, were also highly upregulated in sepsis. Although cancer had much more profound effects on gene transcription in CD8 T cells, common immunosuppressive mechanisms were present in all disorders, suggesting that immunoadjuvant therapies that are effective in one disease may also be efficacious in the others.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31484735      PMCID: PMC6761013          DOI: 10.4049/jimmunol.1900560

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

3.  Immunotherapy for sepsis--a new approach against an ancient foe.

Authors:  Richard S Hotchkiss; Steven Opal
Journal:  N Engl J Med       Date:  2010-07-01       Impact factor: 91.245

4.  Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion.

Authors:  Arnold H Zea; Paulo C Rodriguez; Michael B Atkins; Claudia Hernandez; Sabina Signoretti; Jovanny Zabaleta; David McDermott; David Quiceno; Amanda Youmans; Anne O'Neill; James Mier; Augusto C Ochoa
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

5.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

6.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 7.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

8.  A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis.

Authors:  Jonathan S Boomer; Jennifer Shuherk-Shaffer; Richard S Hotchkiss; Jonathan M Green
Journal:  Crit Care       Date:  2012-06-28       Impact factor: 9.097

9.  A genomic storm in critically injured humans.

Authors:  Wenzhong Xiao; Michael N Mindrinos; Junhee Seok; Joseph Cuschieri; Alex G Cuenca; Hong Gao; Douglas L Hayden; Laura Hennessy; Ernest E Moore; Joseph P Minei; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Bernard H Brownstein; Philip H Mason; Henry V Baker; Celeste C Finnerty; Marc G Jeschke; M Cecilia López; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Brett Arnoldo; Weihong Xu; Yuping Zhang; Steven E Calvano; Grace P McDonald-Smith; David A Schoenfeld; John D Storey; J Perren Cobb; H Shaw Warren; Lyle L Moldawer; David N Herndon; Stephen F Lowry; Ronald V Maier; Ronald W Davis; Ronald G Tompkins
Journal:  J Exp Med       Date:  2011-11-21       Impact factor: 14.307

10.  Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.

Authors:  Caroline Guignant; Alain Lepape; Xin Huang; Hakim Kherouf; Laure Denis; Françoise Poitevin; Christophe Malcus; Aurélie Chéron; Bernard Allaouchiche; François Gueyffier; Alfred Ayala; Guillaume Monneret; Fabienne Venet
Journal:  Crit Care       Date:  2011-03-21       Impact factor: 9.097

View more
  12 in total

1.  Methyltransferase like 7B is upregulated in sepsis and modulates lipopolysaccharide-induced inflammatory response and macrophage polarization.

Authors:  Dan Huang; Hai Yan
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Time Series Transcriptomic Analysis by RNA Sequencing Reveals a Key Role of PI3K in Sepsis-Induced Myocardial Injury in Mice.

Authors:  Xiao Yan; Yun-Long Zhang; Xiao Han; Pang-Bo Li; Shu-Bin Guo; Hui-Hua Li
Journal:  Front Physiol       Date:  2022-06-01       Impact factor: 4.755

3.  Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.

Authors:  Xiaoming Yang; Alex C Rutkovsky; Juhua Zhou; Yin Zhong; Julian Reese; Timothy Schnell; Helmut Albrecht; William B Owens; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2022-04-04       Impact factor: 5.426

4.  Mitohormesis reprogrammes macrophage metabolism to enforce tolerance.

Authors:  Greg A Timblin; Kevin M Tharp; Breanna Ford; Janet M Winchester; Jerome Wang; Stella Zhu; Rida I Khan; Shannon K Louie; Anthony T Iavarone; Johanna Ten Hoeve; Daniel K Nomura; Andreas Stahl; Kaoru Saijo
Journal:  Nat Metab       Date:  2021-05-20

5.  Differences in monocyte subsets are associated with short-term survival in patients with septic shock.

Authors:  Marcela Hortová-Kohoutková; Petra Lázničková; Kamila Bendíčková; Marco De Zuani; Ivana Andrejčinová; Veronika Tomášková; Pavel Suk; Vladimír Šrámek; Martin Helán; Jan Frič
Journal:  J Cell Mol Med       Date:  2020-09-19       Impact factor: 5.310

6.  Human Leukocyte Antigen-DR Isotype Expression in Monocytes and T Cells Interferon-Gamma Release Assay in Septic Patients and Correlation With Clinical Outcome.

Authors:  Marilena Greco; Aurora Mazzei; Salvatore Suppressa; Claudio Palumbo; Tiziano Verri; Giambattista Lobreglio
Journal:  J Clin Med Res       Date:  2021-05-25

7.  A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis.

Authors:  Timothy W Phares; Vinayaka Kotraiah; Chun-Shiang Chung; Jacqueline Unsinger; Monty Mazer; Kenneth E Remy; Cecille D Browne; Peter Buontempo; Marc Mansour; James Pannucci; Alfred Ayala; Richard S Hotchkiss; Gabriel M Gutierrez
Journal:  Shock       Date:  2021-06-01       Impact factor: 3.533

8.  Elevated Interleukin-6 Levels within 72 Hours Post Admission Are Associated with Disease Progression in Nonseptic Critically Ill Children.

Authors:  Lingfang Tan; Jianzhong Dang; Zhongping Liu; Fang Zheng
Journal:  Biomed Res Int       Date:  2020-07-09       Impact factor: 3.411

Review 9.  CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State.

Authors:  Matthew D Martin; Vladimir P Badovinac; Thomas S Griffith
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

10.  Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts.

Authors:  Yini Sun; Jerome C Anyalebechi; He Sun; Tetsuya Yumoto; Ming Xue; Danya Liu; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  JCI Insight       Date:  2021-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.